Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

ZJYL vs INVA vs MPWR vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ZJYL
Jin Medical International Ltd.

Medical - Instruments & Supplies

HealthcareNASDAQ • CN
Market Cap$344M
5Y Perf.-71.5%
INVA
Innoviva, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$1.93B
5Y Perf.+103.5%
MPWR
Monolithic Power Systems, Inc.

Semiconductors

TechnologyNASDAQ • US
Market Cap$77.41B
5Y Perf.+219.8%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-67.4%

ZJYL vs INVA vs MPWR vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ZJYL logoZJYL
INVA logoINVA
MPWR logoMPWR
PRGO logoPRGO
IndustryMedical - Instruments & SuppliesBiotechnologySemiconductorsDrug Manufacturers - Specialty & Generic
Market Cap$344M$1.93B$77.41B$1.61B
Revenue (TTM)$43M$424M$2.79B$4.18B
Net Income (TTM)$5M$504M$616M$-1.82B
Gross Margin35.8%76.2%55.2%34.2%
Operating Margin10.0%14.8%26.1%-4.1%
Forward P/E93.6x7.3x67.2x5.5x
Total Debt$12M$269M$24M$3.97B
Cash & Equiv.$8M$551M$1.10B$532M

ZJYL vs INVA vs MPWR vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ZJYL
INVA
MPWR
PRGO
StockMar 23May 26Return
Jin Medical Interna… (ZJYL)10028.5-71.5%
Innoviva, Inc. (INVA)100203.5+103.5%
Monolithic Power Sy… (MPWR)100319.8+219.8%
Perrigo Company plc (PRGO)10032.6-67.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: ZJYL vs INVA vs MPWR vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: INVA leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Monolithic Power Systems, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. PRGO also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ZJYL
Jin Medical International Ltd.
The Secondary Option

ZJYL lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
INVA
Innoviva, Inc.
The Defensive Pick

INVA carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and valuation efficiency.

  • Lower volatility, beta 0.13, Low D/E 22.9%, current ratio 14.64x
  • PEG 0.71 vs ZJYL's 4.48
  • Lower P/E (7.3x vs 67.2x), PEG 0.71 vs 2.28
  • 118.9% margin vs PRGO's -43.5%
Best for: sleep-well-at-night and valuation efficiency
MPWR
Monolithic Power Systems, Inc.
The Growth Play

MPWR is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 26.4%, EPS growth -65.2%, 3Y rev CAGR 15.9%
  • 24.9% 10Y total return vs INVA's 94.9%
  • 26.4% revenue growth vs PRGO's -2.8%
  • +148.6% vs ZJYL's -86.4%
Best for: growth exposure and long-term compounding
PRGO
Perrigo Company plc
The Income Pick

PRGO is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • Beta 1.18, yield 9.8%, current ratio 2.76x
  • 9.8% yield, 10-year raise streak, vs MPWR's 0.4%, (2 stocks pay no dividend)
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthMPWR logoMPWR26.4% revenue growth vs PRGO's -2.8%
ValueINVA logoINVALower P/E (7.3x vs 67.2x), PEG 0.71 vs 2.28
Quality / MarginsINVA logoINVA118.9% margin vs PRGO's -43.5%
Stability / SafetyINVA logoINVABeta 0.13 vs MPWR's 2.28
DividendsPRGO logoPRGO9.8% yield, 10-year raise streak, vs MPWR's 0.4%, (2 stocks pay no dividend)
Momentum (1Y)MPWR logoMPWR+148.6% vs ZJYL's -86.4%
Efficiency (ROA)INVA logoINVA32.4% ROA vs PRGO's -19.8%, ROIC 14.2% vs 3.7%

ZJYL vs INVA vs MPWR vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ZJYLJin Medical International Ltd.

Segment breakdown not available.

INVAInnoviva, Inc.
FY 2025
Royalty
57.5%$236M
Product
41.8%$172M
License And Other Revenue
0.7%$3M
MPWRMonolithic Power Systems, Inc.
FY 2023
DC To DC Products
94.4%$1.7B
Lighting Control Products
5.6%$102M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

ZJYL vs INVA vs MPWR vs PRGO — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMPWRLAGGINGZJYL

Income & Cash Flow (Last 12 Months)

INVA leads this category, winning 4 of 6 comparable metrics.

PRGO is the larger business by revenue, generating $4.2B annually — 97.3x ZJYL's $43M. INVA is the more profitable business, keeping 118.9% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, MPWR holds the edge at +20.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricZJYL logoZJYLJin Medical Inter…INVA logoINVAInnoviva, Inc.MPWR logoMPWRMonolithic Power …PRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$43M$424M$2.8B$4.2B
EBITDAEarnings before interest/tax$5M$86M$781M$58M
Net IncomeAfter-tax profit$5M$504M$616M-$1.8B
Free Cash FlowCash after capex-$581,373$181M$664M$108M
Gross MarginGross profit ÷ Revenue+35.8%+76.2%+55.2%+34.2%
Operating MarginEBIT ÷ Revenue+10.0%+14.8%+26.1%-4.1%
Net MarginNet income ÷ Revenue+10.9%+118.9%+22.1%-43.5%
FCF MarginFCF ÷ Revenue-1.4%+42.8%+23.8%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year-6.4%+10.6%+20.8%-7.2%
EPS Growth (YoY)Latest quarter vs prior year-105.3%+4.0%-88.4%-56.4%
INVA leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 5 of 7 comparable metrics.

At 6.9x trailing earnings, INVA trades at a 94% valuation discount to MPWR's 123.6x P/E. Adjusting for growth (PEG ratio), INVA offers better value at 0.67x vs ZJYL's 4.48x — a lower PEG means you pay less per unit of expected earnings growth.

MetricZJYL logoZJYLJin Medical Inter…INVA logoINVAInnoviva, Inc.MPWR logoMPWRMonolithic Power …PRGO logoPRGOPerrigo Company p…
Market CapShares × price$344M$1.9B$77.4B$1.6B
Enterprise ValueMkt cap + debt − cash$348M$1.7B$76.3B$5.1B
Trailing P/EPrice ÷ TTM EPS93.62x6.91x123.60x-1.14x
Forward P/EPrice ÷ next-FY EPS est.7.31x67.24x5.53x
PEG RatioP/E ÷ EPS growth rate4.48x0.67x4.19x
EV / EBITDAEnterprise value multiple87.30x8.10x97.90x7.42x
Price / SalesMarket cap ÷ Revenue14.65x4.55x27.74x0.38x
Price / BookPrice ÷ Book value/share12.06x1.65x21.56x0.55x
Price / FCFMarket cap ÷ FCF9.88x116.20x11.12x
PRGO leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

MPWR leads this category, winning 5 of 9 comparable metrics.

INVA delivers a 46.5% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-51 for PRGO. MPWR carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), MPWR scores 6/9 vs ZJYL's 2/9, reflecting solid financial health.

MetricZJYL logoZJYLJin Medical Inter…INVA logoINVAInnoviva, Inc.MPWR logoMPWRMonolithic Power …PRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity+16.9%+46.5%+17.9%-50.7%
ROA (TTM)Return on assets+9.7%+32.4%+15.2%-19.8%
ROICReturn on invested capital+10.3%+14.2%+22.2%+3.7%
ROCEReturn on capital employed+13.8%+12.4%+20.4%+4.3%
Piotroski ScoreFundamental quality 0–92564
Debt / EquityFinancial leverage0.41x0.23x0.01x1.35x
Net DebtTotal debt minus cash$3M-$282M-$1.1B$3.4B
Cash & Equiv.Liquid assets$8M$551M$1.1B$532M
Total DebtShort + long-term debt$12M$269M$24M$4.0B
Interest CoverageEBIT ÷ Interest expense20.63x63.45x-7.20x
MPWR leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

MPWR leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in MPWR five years ago would be worth $46,617 today (with dividends reinvested), compared to $2,767 for ZJYL. Over the past 12 months, MPWR leads with a +148.6% total return vs ZJYL's -86.4%. The 3-year compound annual growth rate (CAGR) favors MPWR at 56.1% vs ZJYL's -26.8% — a key indicator of consistent wealth creation.

MetricZJYL logoZJYLJin Medical Inter…INVA logoINVAInnoviva, Inc.MPWR logoMPWRMonolithic Power …PRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date-51.1%+14.7%+68.5%-13.5%
1-Year ReturnPast 12 months-86.4%+21.7%+148.6%-51.2%
3-Year ReturnCumulative with dividends-60.7%+95.2%+280.3%-58.1%
5-Year ReturnCumulative with dividends-72.3%+94.4%+366.2%-60.1%
10-Year ReturnCumulative with dividends-72.3%+94.9%+2494.7%-77.7%
CAGR (3Y)Annualised 3-year return-26.8%+25.0%+56.1%-25.2%
MPWR leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — INVA and MPWR each lead in 1 of 2 comparable metrics.

INVA is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than MPWR's 2.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MPWR currently trades 94.8% from its 52-week high vs ZJYL's 12.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricZJYL logoZJYLJin Medical Inter…INVA logoINVAInnoviva, Inc.MPWR logoMPWRMonolithic Power …PRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5001.56x0.11x2.27x1.21x
52-Week HighHighest price in past year$18.00$25.15$1662.00$28.44
52-Week LowLowest price in past year$0.12$16.52$613.00$9.23
% of 52W HighCurrent price vs 52-week peak+12.2%+90.7%+94.8%+41.2%
RSI (14)Momentum oscillator 0–10053.739.971.060.9
Avg Volume (50D)Average daily shares traded22K621K577K3.4M
Evenly matched — INVA and MPWR each lead in 1 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: INVA as "Buy", MPWR as "Buy", PRGO as "Hold". Consensus price targets imply 208.9% upside for PRGO (target: $36) vs 2.5% for MPWR (target: $1615). For income investors, PRGO offers the higher dividend yield at 9.81% vs MPWR's 0.37%.

MetricZJYL logoZJYLJin Medical Inter…INVA logoINVAInnoviva, Inc.MPWR logoMPWRMonolithic Power …PRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellBuyBuyHold
Price TargetConsensus 12-month target$40.00$1615.00$36.20
# AnalystsCovering analysts102536
Dividend YieldAnnual dividend ÷ price+0.4%+9.8%
Dividend StreakConsecutive years of raises0810
Dividend / ShareAnnual DPS$5.90$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.2%+0.0%0.0%
PRGO leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

PRGO leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). MPWR leads in 2 (Profitability & Efficiency, Total Returns). 1 tied.

Best OverallMonolithic Power Systems, I… (MPWR)Leads 2 of 6 categories
Loading custom metrics...

ZJYL vs INVA vs MPWR vs PRGO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ZJYL or INVA or MPWR or PRGO a better buy right now?

For growth investors, Monolithic Power Systems, Inc.

(MPWR) is the stronger pick with 26. 4% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Innoviva, Inc. (INVA) offers the better valuation at 6. 9x trailing P/E (7. 3x forward), making it the more compelling value choice. Analysts rate Innoviva, Inc. (INVA) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ZJYL or INVA or MPWR or PRGO?

On trailing P/E, Innoviva, Inc.

(INVA) is the cheapest at 6. 9x versus Monolithic Power Systems, Inc. at 123. 6x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innoviva, Inc. wins at 0. 71x versus Monolithic Power Systems, Inc. 's 2. 28x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — ZJYL or INVA or MPWR or PRGO?

Over the past 5 years, Monolithic Power Systems, Inc.

(MPWR) delivered a total return of +366. 2%, compared to -72. 3% for Jin Medical International Ltd. (ZJYL). Over 10 years, the gap is even starker: MPWR returned +25. 3% versus PRGO's -77. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ZJYL or INVA or MPWR or PRGO?

By beta (market sensitivity over 5 years), Innoviva, Inc.

(INVA) is the lower-risk stock at 0. 11β versus Monolithic Power Systems, Inc. 's 2. 27β — meaning MPWR is approximately 1901% more volatile than INVA relative to the S&P 500. On balance sheet safety, Monolithic Power Systems, Inc. (MPWR) carries a lower debt/equity ratio of 1% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — ZJYL or INVA or MPWR or PRGO?

By revenue growth (latest reported year), Monolithic Power Systems, Inc.

(MPWR) is pulling ahead at 26. 4% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Innoviva, Inc. grew EPS 816. 7% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, MPWR leads at 15. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ZJYL or INVA or MPWR or PRGO?

Innoviva, Inc.

(INVA) is the more profitable company, earning 63. 8% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 63. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INVA leads at 38. 5% versus 8. 1% for PRGO. At the gross margin level — before operating expenses — INVA leads at 72. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ZJYL or INVA or MPWR or PRGO more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Innoviva, Inc. (INVA) is the more undervalued stock at a PEG of 0. 71x versus Monolithic Power Systems, Inc. 's 2. 28x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Perrigo Company plc (PRGO) trades at 5. 5x forward P/E versus 67. 2x for Monolithic Power Systems, Inc. — 61. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 208. 9% to $36. 20.

08

Which pays a better dividend — ZJYL or INVA or MPWR or PRGO?

In this comparison, PRGO (9.

8% yield), MPWR (0. 4% yield) pay a dividend. ZJYL, INVA do not pay a meaningful dividend and should not be held primarily for income.

09

Is ZJYL or INVA or MPWR or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Innoviva, Inc.

(INVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 11)). Monolithic Power Systems, Inc. (MPWR) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (INVA: +95. 6%, MPWR: +25. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ZJYL and INVA and MPWR and PRGO?

These companies operate in different sectors (ZJYL (Healthcare) and INVA (Healthcare) and MPWR (Technology) and PRGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ZJYL is a small-cap high-growth stock; INVA is a small-cap high-growth stock; MPWR is a mid-cap high-growth stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while ZJYL, INVA, MPWR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ZJYL

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 6%
Run This Screen
Stocks Like

INVA

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 71%
Run This Screen
Stocks Like

MPWR

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 10%
  • Net Margin > 13%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ZJYL and INVA and MPWR and PRGO on the metrics below

Revenue Growth>
%
(ZJYL: -6.4% · INVA: 10.6%)
Net Margin>
%
(ZJYL: 10.9% · INVA: 118.9%)
P/E Ratio<
x
(ZJYL: 93.6x · INVA: 6.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.